Possible use of indocyanine green in the management of endometriosis

Czech version

Authors: Vladimír Baláž ^1,2 ; Martin Syrůček ³; Jiří Presl ^2,4
Authors‘ workplace: Gynekologické oddělení, Nemocnice na Homolce, Praha ¹; LF UK v Plzni ²; Oddělení patologie, Nemocnice Na Homolce, Praha ³; Gynekologicko-porodnická klinika FN Plzeň ⁴
Published in: Ceska Gynekol 2025; 90(3): 238-246
Category:
doi: https://doi.org/10.48095/cccg2025238

Overview

Endometriosis affects approximately 10% of women of fertile age and its deep infiltrating form causes serious consequences for fertility, clinical problems depending on which organs are affected (urinary and digestive tract) and causes serious pain which seriously impairs quality of life. Resection of the affected tissue tend to be complex and often require multidisciplinary approach. Resection in the field of severe deep infiltrating endometriosis is complicated by the difficulty of resection line identification. Although we are able to perform most of the resections laparoscopically, there is still significant risk of intra and postoperative complications, the most serious of which is the formation of rectovaginal fistulas. Identification of boundaries of the endometrial nodule and preservation of tissue vitality is crucial in resection procedures. Endometriotic nodules, based on the pathogenesis of the lesion, have various vascularity and therefore different perfusion patterns. According to nature of tissue and the degree of vascularization, most deep infiltrating nodules have rather hypoperfusion pattern. A substance that would be able to guide the resection by live monitoring of the tissue perfusion, could have useful therapeutic applications. Such substance could be the fluorescent dye indocyanine green. With resection guidance by fluorescence dye, we could be able of pathogenesis oriented management of the disease and therefore perform more gentle tissue preparation, with less collateral damage, reduction of intra and postoperative complications, and thus improvement of the quality of life of patients in terms of pain, risk of recurrence, and preservation of fertility.

Keywords:

indocyanine green – deep infiltrating endometriosis – tissue perfusion – guided resection

Sources

1. Viganò P, Parazzini F, Somigliana E et al. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 2004; 18 (2): 177–200. doi: 10.1016/j.bpobgyn.2004. 01.007.

2. Abrão MS, Petraglia F, Falcone T et al. Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management. Hum Reprod Update 2015; 21 (3): 329–339. doi: 10.1093/humupd/dmv003.

3. Sabapathy V, Mentam J, Jacob PM et al. Noninvasive optical imaging and in vivo cell tracking of indocyanine green labeled human stem cells transplanted at superficial or in-depth tissue of SCID mice. Stem Cells Int 2015; 2015: 606415. doi: 10.1155/2015/606415.

4. Kufa R. Indocyaninová zeleň vlastnosti, současné možnosti a trendy využité v klinických aplikacích. Klin Farmakol Farm 2013; 27 (2): 89–91.

5. Loverro M, Bizzarri N, Capomacchia FM et al. Indocyanine green fluorescence applied to gynecologic oncology: beyond sentinel lymph node. Int J Surg 2024; 110 (6): 3641–3653. doi: 10.1097/JS9.0000000000001318.

6. Hollins B, Noe B, Henderson JM. Fluorometric determination of indocyanine green in plasma. Clin Chem 1987; 33 (6): 765–768.

7. Hope-Ross M, Yannuzzi LA, Gragoudas ES et al. Adverse reactions due to indocyanine green. Ophthalmology 1994; 101 (3): 529–533. doi: 10.1016/s0161-6420 (94) 31303-0.

8. Capasso I, Cucinella G, Volcheck G et al. Let go of the myth: safety of indocyanine green for sentinel lymph node mapping in endometrial cancer. Int J Gynecol Cancer 2024; 34 (1): 80–87. doi: 10.1136/ijgc-2023-004918.

9. Bourdel N, Jaillet L, Bar-Shavit Y et al. Indocyanine green in deep infiltrating endometriosis: a preliminary feasibility study to examine vascularization after rectal shaving. Fertil Steril 2020; 114 (2): 367–373. doi: 10.1016/j.fertnstert.2020.03.042.

10. De Neef A, Cadière GB, Bourgeois P et al. Fluorescence of deep infiltrating endometriosis during laparoscopic surgery: a preliminary report on 6 cases. Surg Innov 2018; 25 (5): 450–454. doi: 10.1177/1553350618785486.

11. Turco LC, Vizzielli G, Vargiu V et al. Near-infrared imaging with indocyanine green for the treatment of endometriosis: results from the gre-endo trial. Front Oncol 2021; 11: 737938. doi: 10.3389/fonc.2021.737938.

12. Siegenthaler F, Knabben L, Mohr S et al. Visualization of endometriosis with laparoscopy and near-infrared optics with indocyanine green. Acta Obstet Gynecol Scand 2020; 99 (5): 591–597. doi: 10.1111/aogs.13803.

13. Kondo A, Kumamoto K, Asano E et al. Indocyanine green fluorescence imaging during laparoscopic rectal cancer surgery could reduce the incidence of anastomotic leakage: a single institutional retrospective cohort study. World J Surg Oncol 2022; 20 (1): 397. doi: 10.1186/s12957-022-02856-z.

14. Boni L, David G, Dionigi G et al. Indocyanine green-enhanced fluorescence to assess bowel perfusion during laparoscopic colorectal resection. Surg Endosc 2016; 30 (7): 2736–2742. doi: 10.1007/s00464-015-4540-z.

15. Jafari MD, Wexner SD, Martz JE et al. Perfusion assessment in laparoscopic left-sided/anterior resection (PILLAR II): a multi-institutional study. J Am Coll Surg 2015; 220 (1): 82.e1–92.e1. doi: 10.1016/j.jamcollsurg.2014.09.015.

16. Burks FN, Santucci RA. Management of iatrogenic ureteral injury. Ther Adv Urol 2014; 6 (3): 115–124. doi: 10.1177/1756287214526767.

17. Cabanes M, Boria F, Hernández Gutiérrez A et al. Intra-operative identification of ureters using indocyanine green for gynecological oncology procedures. Int J Gynecol Cancer 2020; 30 (2): 278. doi: 10.1136/ijgc-2019-000895.

18. Raimondo D, Borghese G, Mabrouk M et al. Use of indocyanine green for intraoperative perfusion assessment in women with ureteral endometriosis: a preliminary study. J Minim Invasive Gynecol 2021; 28 (1): 42–49. doi: 10.1016/j.jmig.2020.04.004.

19. Watrowski R, Kostov S, Alkatout I. Complications in laparoscopic and robotic-assisted surgery: definitions, classifications, incidence and risk factors – an up-to-date review. Wideochir Inne Tech Maloinwazyjne 2021; 16 (3): 501–525. doi: 10.5114/wiitm.2021.108800.

20. Beran BD, Shockley M, Padilla PF et al. Laser angiography to assess the vaginal cuff during robotic hysterectomy. JSLS 2018; 22 (2): e2018.00001. doi: 10.4293/JSLS.2018.00001.

21. He K, Li P, Zhang Z et al. Intraoperative near-infrared fluorescence imaging can identify pelvic nerves in patients with cervical cancer in real time during radical hysterectomy. Eur J Nucl Med Mol Imaging 2022; 49 (8): 2929–2937. doi: 10.1007/s00259-022-05686-z.

22. Kanno K, Aiko K, Yanai S et al. Clinical use of indocyanine green during nerve-sparing surgery for deep endometriosis. Fertil Steril 2021; 116 (1): 269–271. doi: 10.1016/j.fertnstert.2021. 03.014.

23. Zhou K, Zhou S, Du L et al. Safety and effectiveness of indocyanine green fluorescence imaging-guided laparoscopic hepatectomy for hepatic tumor: a systematic review and meta-analysis. Front Oncol 2024; 13: 1309593. doi: 10.3389/fonc.2023.1309593.

24. Donnez O, Roman H. Choosing the right surgical technique for deep endometriosis: shaving, disc excision, or bowel resection? Fertil Steril 2017; 108 (6): 931–942. doi: 10.1016/j.fertnstert.2017.09.006.

25. Remorgida V, Ragni N, Ferrero S et al. How complete is full thickness disc resection of bowel endometriotic lesions? A prospective surgical and histological study. Hum Reprod 2005; 20 (8): 2317–2320. doi: 10.1093/humrep/ dei047.

26. Badescu A, Roman H, Aziz M et al. Mapping of bowel occult microscopic endometriosis implants surrounding deep endometriosis nodules infiltrating the bowel. Fertil Steril 2016; 105 (2): 430.e26–434.e26. doi: 10.1016/j.fertnstert.2015.11.006.

27. Roman H, Hennetier C, Darwish B et al. Bowel occult microscopic endometriosis in resection margins in deep colorectal endometriosis specimens has no impact on short-term postoperative outcomes. Fertil Steril 2016; 105 (2): 423.e7–429.e7. doi: 10.1016/j.fertnstert.2015.09.030.

28. Orellana R, García-Solares J, Donnez J et al. Important role of collective cell migration and nerve fiber density in the development of deep nodular endometriosis. Fertil Steril 2017; 107 (4): 987.e5–995.e5. doi: 10.1016/j.fertnstert.2017.01.005.

29. Raimondo D, Mastronardi M, Mabrouk M et al. Rectosigmoid endometriosis vascular patterns at intraoperative indocyanine green angiography and their correlation with clinicopathological data. Surg Innov 2020; 27 (5): 474–480. doi: 10.1177/1553350620930147.

30. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997; 68 (4): 585–596. doi: 10.1016/s0015-0282 (97) 00191-x.

31. Laschke MW, Menger MD. Basic mechanisms of vascularization in endometriosis and their clinical implications. Hum Reprod Update 2018; 24 (2): 207–224. doi: 10.1093/humupd/dmy001.

32. Anaf V, Simon P, Fayt I et al. Smooth muscles are frequent components of endometriotic lesions. Hum Reprod 2000; 15 (4): 767–771. doi: 10.1093/humrep/15.4.767.

33. Itoga T, Matsumoto T, Takeuchi H et al. Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis. Pathol Int 2003; 53 (6): 371–375. doi: 10.1046/j.1440-1827.2003.01483.x.

34. Vigano P, Candiani M, Monno A et al. Time to redefine endometriosis including its pro-fibrotic nature. Hum Reprod 2018; 33 (3): 347–352. doi: 10.1093/humrep/dex354.

35. Odagiri K, Konno R, Fujiwara H et al. Smooth muscle metaplasia and innervation in interstitium of endometriotic lesions related to pain. Fertil Steril 2009; 92 (5): 1525–1531. doi: 10.1016/j.fertnstert.2008.08.101.

36. Anaf V, Simon P, El Nakadi I et al. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 2000; 15 (8): 1744–1750. doi: 10.1093/humrep/15.8.1744.

37. Anaf V, El Nakadi I, Simon P et al. Preferential infiltration of large bowel endometriosis along the nerves of the colon. Hum Reprod 2004; 19 (4): 996–1002. doi: 10.1093/humrep/deh150.

38. Anaf V, Simon P, El Nakadi I et al. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod 2002; 17 (7): 1895–1900. doi: 10.1093/humrep/17.7.1895.

39. Donnez J, Nisolle M, Casanas-Roux F et al. Stereometric evaluation of peritoneal endometriosis and endometriotic nodules of the rectovaginal septum. Hum Reprod 1996; 11 (1): 224–228. doi: 10.1093/oxfordjournals.humrep.a019024.

40. Kitano T, Matsumoto T, Takeuchi H et al. Expression of estrogen and progesterone receptors in smooth muscle metaplasia of rectovaginal endometriosis. Int J Gynecol Pathol 2007; 26 (2): 124–129. doi: 10.1097/01.pgp.0000235067.16054.dd.

41. González-Foruria I, Santulli P, Chouzenoux S et al. Dysregulation of the ADAM17/Notch signalling pathways in endometriosis: from oxidative stress to fibrosis. Mol Hum Reprod 2017; 23 (7): 488–499. doi: 10.1093/molehr/gax028.

42. Koninckx PR, Ussia A, Adamyan L et al. Deep endometriosis: definition, diagnosis, and treatment. Fertil Steril 2012; 98 (3): 564–571. doi: 10.1016/j.fertnstert.2012.07.1061.

43. Koninckx PR, Fernandes R, Ussia A et al. Pathogenesis based diagnosis and treatment of endometriosis. Front Endocrinol (Lausanne) 2021; 12: 745548. doi: 10.3389/fendo.2021. 745548.

44. Levey KA. Use of fluorescence imaging technology to identify peritoneal endometriosis: a case report of new technology. Surg Laparosc Endosc Percutan Tech 2014; 24 (2): e63–e65. doi: 10.1097/SLE.0b013e31828fa28d.

45. Vizzielli G, Cosentino F, Raimondo D et al. Real three-dimensional approach vs two-dimensional camera with and without real-time near-infrared imaging with indocyanine green for detection of endometriosis: a case-control study. Acta Obstet Gynecol Scand 2020; 99 (10): 1330–1338. doi: 10.1111/aogs.13866.

46. Ianieri MM, Della Corte L, Campolo F et al. Indocyanine green in the surgical management of endometriosis: a systematic review. Acta Obstet Gynecol Scand 2021; 100 (2): 189–199. doi: 10.1111/aogs.13971.

ORCID autorů

V. Baláž 0009-0007-7387-2191

J. Presl 0000-0001-7632-4069

Doručeno/Submitted: 7. 2. 2025

Přijato/Accepted: 7. 2. 2025

MUDr. Vladimír Baláž

Gynekologické oddělení

Nemocnice na Homolce

Roentgenova 37/2

150 30 Praha 5

balazvladimir0@gmail.com